Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
CA Stock MarketDetailed Quotes
Voyageur Pharmaceuticals Ltd (VM)
- 0.120
- 0.0000.00%
15min DelayMarket Closed Apr 17 16:00 ET
21.43MMarket Cap-6.00P/E (TTM)
0.120High0.115Low47.21KVolume0.120Open0.120Prev Close5.56KTurnover0.36052wk High0.03%Turnover Ratio178.59MShares0.10052wk Low-0.02EPS TTM19.49MFloat Cap0.400Historical HighLossP/E (Static)162.39MShs Float0.035Historical Low-0.02EPS LYR4.17%Range %--Dividend TTM17.14P/B1Lot Size--Div Yield TTM
Voyageur Pharmaceuticals Ltd (VM) Cash Flow
Quarterly+Annual
YOY
| (FY)Nov 30, 2025 | (Q4)Nov 30, 2025 | (Q3)Aug 31, 2025 | (Q2)May 31, 2025 | (Q1)Feb 28, 2025 | (FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -856.96%-2.89M | -1,299.10%-369.98K | -2,352.15%-883.27K | -37.72%-260.69K | -653.18%-1.38M | 69.50%-302.29K | -32.79%30.86K | 146.78%39.22K | 60.49%-189.29K | 61.39%-183.07K |
| Net income from continuing operations | -106.92%-3.53M | -88.86%-865.95K | -265.09%-1.3M | 3.23%-544.25K | -148.54%-817.56K | -21.99%-1.71M | -62.40%-458.51K | -193.05%-357.39K | 9.51%-562.4K | 11.97%-328.95K |
| Operating gains losses | -98.03%20 | 277.46%9.05K | -287.34%-4.8K | -321.23%-13.51K | 642.16%9.28K | 181.97%1.01K | ---5.1K | ---1.24K | --6.11K | --1.25K |
| Depreciation and amortization | -27.83%1.13K | -27.81%283 | -27.99%283 | -27.55%284 | -27.99%283 | -28.15%1.57K | -28.21%392 | -28.15%393 | -28.21%392 | -28.02%393 |
| Asset impairment expenditure | --0 | ---- | ---- | ---- | ---- | -83.66%7.94K | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | 94.09%809.68K | -508.64%-125.52K | 229.72%241.24K | 24.68%298.67K | 216.07%395.3K | 78.25%417.16K | -268.83%-20.62K | 369.35%73.16K | 7.80%239.55K | 367.25%125.07K |
| Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1 |
| Change In working capital | -117.50%-171.07K | 20.80%612.15K | -43.01%184.82K | -101.48%-1.88K | -5,140.96%-966.15K | 787.21%977.27K | 99.81%506.76K | 299.91%324.29K | 231.33%127.05K | 114.99%19.17K |
| -Change in receivables | -408.26%-81.98K | -15.84%-16.88K | -193.23%-30.71K | -79.08%-16.4K | -199.51%-17.99K | -33.85%-16.13K | -56.94%-14.58K | -159.10%-10.47K | -43.12%-9.16K | 228.36%18.08K |
| -Change in inventory | 131.24%17.65K | 283.44%103.64K | ---68.11K | ---17.88K | --0 | ---56.5K | ---56.5K | --0 | --0 | --0 |
| -Change in prepaid assets | -112.61%-72.03K | -2,069.10%-98.26K | 10.62%50.86K | -97.72%1.06K | 80.41%-25.7K | -166.27%-33.88K | -70.47%4.99K | 494.81%45.98K | -4.55%46.33K | -4,816.94%-131.18K |
| -Change in payables and accrued expense | -112.13%-131.48K | -8.03%526.87K | -19.40%232.77K | -65.12%31.35K | -797.39%-922.47K | 1,424.80%1.08M | 132.85%572.85K | 284.94%288.78K | 164.71%89.88K | 219.09%132.27K |
| -Change in other current liabilities | --96.77K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -856.96%-2.89M | -1,299.10%-369.98K | -2,352.14%-883.27K | -37.72%-260.69K | -653.18%-1.38M | 69.50%-302.29K | -32.79%30.86K | 146.78%39.22K | 60.49%-189.29K | 61.39%-183.07K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -62.71%-270.02K | -160.53%-92.02K | -109.19%-115.03K | 46.08%-20.54K | -13.01%-42.43K | 5.02%-165.96K | -6.37%-35.32K | -0.45%-54.99K | 15.05%-38.1K | 10.44%-37.55K |
| Net other investing changes | -62.71%-270.02K | -160.53%-92.02K | -109.19%-115.03K | 46.08%-20.54K | -13.01%-42.43K | 5.02%-165.96K | -6.37%-35.32K | -0.45%-54.99K | 15.05%-38.1K | 10.44%-37.55K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -62.71%-270.02K | -160.53%-92.02K | -109.19%-115.03K | 46.08%-20.54K | -13.01%-42.43K | 5.02%-165.96K | -6.37%-35.32K | -0.45%-54.99K | 15.05%-38.1K | 10.44%-37.55K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 416.73%3.26M | -228.20%-214.1K | 27,643.40%1.56M | 324.56%20.63K | 304.61%1.89M | -44.41%631.73K | 1,436.00%167K | -65.54%5.63K | -138.59%-9.19K | -58.80%468.28K |
| Net common stock issuance | 39.42%913.88K | --0 | --0 | --0 | 85.14%913.88K | -45.37%655.5K | 1,436.00%167K | -96.76%530 | -46.30%-5.63K | -58.86%493.6K |
| Proceeds from stock option exercised by employees | 47,542.08%2.43M | --12.77K | 31,871.12%1.63M | --90.18K | --696.9K | --5.1K | --0 | --5.1K | --0 | --0 |
| Net other financing activities | -181.32%-81.23K | ---226.87K | ---68.74K | -1,856.75%-69.54K | 1,221.23%283.92K | 54.49%-28.88K | --0 | --0 | ---3.55K | 60.09%-25.32K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 416.73%3.26M | -228.20%-214.1K | 27,643.40%1.56M | 324.56%20.63K | 304.61%1.89M | -44.41%631.73K | 1,436.00%167K | -65.54%5.63K | -138.59%-9.19K | -58.80%468.28K |
| Net cash flow | ||||||||||
| Beginning cash position | 7,840.96%165.57K | 30,975.95%943.16K | 2,773.30%378.39K | 155.85%638.99K | 7,840.96%165.57K | -93.39%2.09K | 61.26%3.04K | -89.39%13.17K | -61.69%249.75K | -93.39%2.09K |
| Current changes in cash | -37.92%101.49K | -515.98%-676.1K | 5,673.02%564.77K | -10.15%-260.6K | 91.15%473.42K | 654.63%163.48K | 79,966.01%162.53K | 91.71%-10.13K | 55.18%-236.58K | -60.08%247.67K |
| End cash Position | 61.29%267.05K | 61.29%267.05K | 30,975.95%943.16K | 2,773.30%378.39K | 155.85%638.99K | 7,840.96%165.57K | 7,840.96%165.57K | 61.26%3.04K | -89.39%13.17K | -61.69%249.75K |
| Free cash from | -856.96%-2.89M | -1,299.10%-369.98K | -2,352.14%-883.27K | -37.72%-260.69K | -653.18%-1.38M | 69.50%-302.29K | -32.79%30.86K | 146.78%39.22K | 60.49%-189.29K | 61.39%-183.07K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm